Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma.

Glaucoma is the leading cause for blindness affecting 60 million people worldwide. The optineurin (OPTN) E50K mutation was first identified in familial primary open-angle glaucoma (POAG), the onset of which is not associated with intraocular pressure (IOP) elevation, and is classified as normal-tension glaucoma (NTG). Optineurin (OPTN) is a multifunctional protein and its mutations are associated with neurodegenerative diseases such as POAG and amyotrophic lateral sclerosis (ALS). We have previously described an E50K mutation-carrying transgenic (E50K-tg) mouse that exhibited glaucomatous phenotypes of decreased retinal ganglion cells (RGCs) and surrounding cell death at normal IOP. Further phenotypic analysis of these mice revealed persistent reactive gliosis and E50K mutant protein deposits in the outer plexiform layer (OPL). Over-expression of E50K in HEK293 cells indicated accumulation of insoluble OPTN in the endoplasmic reticulum (ER). This phenomenon was consistent with the results seen in neurons derived from induced pluripotent stem cells (iPSCs) from E50K mutation-carrying NTG patients. The E50K mutant strongly interacted with TANK-binding kinase 1 (TBK1), which prohibited the proper oligomerization and solubility of OPTN, both of which are important for OPTN intracellular transition. Treatment with a TBK1 inhibitor, BX795, abrogated the aberrant insolubility of the E50K mutant. Here, we delineated the intracellular dynamics of the endogenous E50K mutant protein for the first time and demonstrated how this mutation causes OPTN insolubility, in association with TBK1, to evoke POAG.

[1]  A. Robin,et al.  TBK1 and Flanking Genes in Human Retina , 2014, Ophthalmic genetics.

[2]  Young H. Kwon,et al.  Identification of Proteins that Interact with TANK Binding Kinase 1 and Testing for Mutations Associated with Glaucoma , 2013, Current eye research.

[3]  F. Shewmaker,et al.  A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity , 2012, Molecular microbiology.

[4]  H. Okano,et al.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.

[5]  Yaou Duan,et al.  Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids , 2012, Proceedings of the National Academy of Sciences.

[6]  Ping Liu,et al.  Overexpressed mutant optineurin(E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway , 2012, Molecular Biology Reports.

[7]  Zhijian J. Chen,et al.  STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway , 2012, Science Signaling.

[8]  R. Ritch,et al.  Confirmation of TBK1 duplication in normal tension glaucoma. , 2012, Experimental eye research.

[9]  B. Yue,et al.  Cellular and molecular biology of optineurin. , 2012, International review of cell and molecular biology.

[10]  Z. Lasiecka,et al.  Mechanisms of polarized membrane trafficking in neurons — Focusing in on endosomes , 2011, Molecular and Cellular Neuroscience.

[11]  A. Bosserhoff,et al.  Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. , 2011, Experimental eye research.

[12]  P. Cohen,et al.  Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon β* , 2011, The Journal of Biological Chemistry.

[13]  Adam P. DeLuca,et al.  Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa , 2011, Proceedings of the National Academy of Sciences.

[14]  Sebastian A. Wagner,et al.  Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth , 2011, Science.

[15]  Young H. Kwon,et al.  Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. , 2011, Human molecular genetics.

[16]  R. Takahashi,et al.  Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation , 2011, Acta Neuropathologica.

[17]  A. Reichenbach,et al.  Effects of ischemia-reperfusion on physiological properties of Müller glial cells in the porcine retina. , 2011, Investigative ophthalmology & visual science.

[18]  Ivana K. Kim,et al.  In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. , 2011, Investigative ophthalmology & visual science.

[19]  S. Chintala,et al.  Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells , 2011, PloS one.

[20]  J. Sellers,et al.  Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane , 2011, Molecular biology of the cell.

[21]  A. Mori,et al.  Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration , 2010, Neuroscience Letters.

[22]  Y. Qiu,et al.  Processing of Optineurin in Neuronal Cells* , 2010, The Journal of Biological Chemistry.

[23]  Hideyuki Okano,et al.  Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury , 2010, Proceedings of the National Academy of Sciences.

[24]  Shinsuke Yuasa,et al.  Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. , 2010, Cell stem cell.

[25]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[26]  S. Noda,et al.  Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice , 2010, Human molecular genetics.

[27]  V. Radha,et al.  Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant , 2010, BMC Cell Biology.

[28]  K. Ishii,et al.  Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response , 2009, Proceedings of the National Academy of Sciences.

[29]  P. Cohen,et al.  Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. , 2009, The Journal of biological chemistry.

[30]  P. Cohen,et al.  Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma , 2008, FEBS letters.

[31]  V. Radha,et al.  A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. , 2007, Investigative ophthalmology & visual science.

[32]  B. Yue,et al.  Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. , 2006, The American journal of pathology.

[33]  J. Haines,et al.  Distribution of Optineurin Sequence Variations in an Ethnically Diverse Population of Low-tension Glaucoma Patients From the United States , 2006, Journal of glaucoma.

[34]  A. Iwase,et al.  Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. , 2006, Ophthalmology.

[35]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[36]  H. Sitte,et al.  Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. , 2006, Handbook of experimental pharmacology.

[37]  D. Selkoe,et al.  Dopamine covalently modifies and functionally inactivates parkin , 2005, Nature Medicine.

[38]  S. Bhattacharya,et al.  Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. , 2005, Investigative ophthalmology & visual science.

[39]  G. Spudich,et al.  Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis , 2005, The Journal of cell biology.

[40]  A. Iwase,et al.  The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. , 2004, Ophthalmology.

[41]  T. Rezaie,et al.  Optineurin in primary open angle glaucoma. , 2003, Ophthalmology clinics of North America.

[42]  Pascal Kahlem,et al.  Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. , 2002, Journal of cell science.

[43]  R. Ritch,et al.  Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin , 2002, Science.

[44]  S. Nagata,et al.  pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.

[45]  D. Selkoe,et al.  Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.